Novel haplotypes in 17q21 are associated with progressive supranuclear palsy

Pau Pastor, Mario Ezquerra, J. Christian Perez, Sumi Chakraverty, Joanne Norton, Brad A. Racette, Dan McKeel, Joel S. Perlmutter, Eduardo Tolosa, Alison M. Goate

Research output: Contribution to journalArticlepeer-review

54 Scopus citations

Abstract

Progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) are sporadic neurodegenerative diseases presenting as atypical parkinsonian disorders, characterized by the presence of tau-positive neurofibrillary tangles. Recently, an extended haplotype (H1E) of 787.6kb that comprises several genes including MAPT showed increased association with PSP. The objective of this study was to determine the size of the H1E haplotype associated with PSP and CBD in different populations and to identify specific subhaplotypes in the background of H1E haplotype. Nineteen single nucleotide polymorphisms (SNPs) in the 17q21 region were genotyped in two case-control samples. The SNPs that were associated with higher risk for the disease in the homozygous state delimit a region of more that 1Mb. Haplotype analyses in the Spanish sample showed that the most frequent haplotype found among the patients (H1E′), which extends 1.04Mb and contains several genes such as MAPT, CRHR1, IMP5, Saitohin, WTN3, and NSF. A specific subhaplotype (H1E′A) was present in 16% of PSP patients but was not observed in the controls. Furthermore, the H2E′A haplotype, was rarely present in the disease group suggesting that it plays a protective role. The identification of these specific subhaplotypes that modify risk for PSP/CBD supports the hypothesis that a pathogenic allele exists in a subgroup of PSP patients.

Original languageEnglish
Pages (from-to)249-258
Number of pages10
JournalAnnals of neurology
Volume56
Issue number2
DOIs
StatePublished - Aug 2004

Fingerprint

Dive into the research topics of 'Novel haplotypes in 17q21 are associated with progressive supranuclear palsy'. Together they form a unique fingerprint.

Cite this